Search results
Bristol-Myers Squibb (NYSE:BMY) Shares Down 2.6%
ETF DAILY NEWS· 6 hours agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) shares fell 2.6% during mid-day trading on Thursday . The stock traded as low as $41.30 and last traded at $41.32. 6,200,453 shares traded hands ...
Options Solutions LLC Purchases 1,805 Shares of Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 8 hours agoOptions Solutions LLC boosted its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 13.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities ...
Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know
Zacks via Yahoo Finance· 4 days agoBristol Myers Squibb (BMY) ended the recent trading session at $43.02, demonstrating a +1.06% swing...
Bristol Myers Squibb's Augtyro Gets FDA Accelerated Approval
Morningstar· 2 days agoBy Denny Jacob Bristol Myers Squibb disclosed that the U.S. Food and Drug Administration granted accelerated approval of Augtyro. The biopharmaceutical product developer said the approval is based on results from a Phase 1/2 study which
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 2 days agoBristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you...
Smart Money Is Betting Big In BMY Options - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 18 hours agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Bristol-Myers Squibb . Looking at options history for Bristol-Myers Squibb BMY we detected ...
Wasatch Advisors LP Has $4.48 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 3 days agoWasatch Advisors LP boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.2% during the fourth quarter, according to the company in its most recent Form 13F filing ...
Why Bristol Myers Squibb Is A Top Socially Responsible Dividend Stock
Forbes· 5 days agoBristol Myers Squibb has been named a Top Socially Responsible Dividend Stock
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Digital Journal· 3 days agoPRESS RELEASE Published June 12, 2024 ACCESSWIRE Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment ...
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Zacks via Yahoo Finance· 22 hours agoThe FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric...
